Co-Diagnostics annual shareholder meeting lacks quorum
CODX•Co-Diagnostics’ October 14, 2026, reconvened annual shareholder meeting lacked a quorum, and none of the proposals received approval. The company plans to seek approval at a special shareholder meeting.
1. Meeting ends without vote
Co-Diagnostics’ reconvened annual shareholder meeting on October 14, 2026, lacked a quorum, so none of the proposals received approval. Earlier sessions on September 3, September 24 and September 30 also failed to achieve a quorum. The company ended the meeting without another adjournment and intends to seek approval of the proposals at a special shareholder meeting.
